Clearance of head and neck involvement in plaque psoriasis with tildrakizumab treatment in the phase 3 reSURFACE 1 study. (3rd August 2020) - Menter, M.A.; Murakawa, G.J.; Glover, H.; Mendelsohn, A.M.; Parno, J.; Rozzo, S.J.; Davidson, D.; Gupta, A.K.